Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Other
Cefuroxime is a second-generation cephalosporin antibiotic used to treat a wide variety of bacterial infections. It works by inhibiting bacterial cell wall synthesis and is available in both oral and parenteral forms.
Name
Cefuroxime
Raw Name
CEFUROXIME SODIUM
Category
Other
Salt Form
Sodium
Drug Count
3
Variant Count
10
Last Verified
February 17, 2026
RxCUI
1665444, 1665449, 309101
UNII
R8A7M9MY61
About Cefuroxime
Cefuroxime is a second-generation cephalosporin antibiotic used to treat a wide variety of bacterial infections. It works by inhibiting bacterial cell wall synthesis and is available in both oral and parenteral forms.
Detailed information about Cefuroxime
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Cefuroxime.
Clinically, Cefuroxime exists in two primary forms: Cefuroxime Sodium (for injection or intravenous infusion) and Cefuroxime Axetil (an oral prodrug). The sodium salt is typically reserved for more severe infections requiring hospitalization or for surgical prophylaxis, while the oral form is widely prescribed for community-acquired infections. It is important to note that Cefuroxime is only effective against bacterial infections; it will not work for viral infections such as the common cold, the flu, or COVID-19. Misuse of antibiotics can lead to decreased effectiveness in the future through the development of antibiotic resistance.
At the molecular level, Cefuroxime is a bactericidal agent, meaning it actively kills bacteria rather than just inhibiting their growth. It achieves this by targeting the bacterial cell wall, a structure essential for the survival of the organism. Bacteria maintain a high internal osmotic pressure; without a rigid cell wall, they would swell and eventually burst (lyse).
Cefuroxime works by binding to and inactivating specific enzymes known as Penicillin-Binding Proteins (PBPs). These enzymes are located on the inner membrane of the bacterial cell wall and are responsible for the final stages of peptidoglycan synthesis—the cross-linking process that gives the cell wall its strength. By inhibiting these PBPs, Cefuroxime prevents the bacteria from constructing a stable cell wall. This leads to the activation of bacterial autolytic enzymes (autolysins), which further break down the existing wall, ultimately resulting in the death of the bacterial cell. Because human cells do not possess a peptidoglycan cell wall, Cefuroxime is highly selective for bacteria, which contributes to its safety profile in humans.
The pharmacokinetics of Cefuroxime describe how the body absorbs, distributes, metabolizes, and excretes the drug. Understanding these parameters is vital for ensuring effective therapy and minimizing toxicity.
Cefuroxime is FDA-approved for a wide range of indications. Your healthcare provider will determine the appropriate use based on the suspected or confirmed bacterial pathogen. Common indications include:
Cefuroxime is available in several formulations to accommodate different clinical needs:
> Important: Only your healthcare provider can determine if Cefuroxime is right for your specific condition. Do not attempt to self-diagnose or use leftover antibiotics, as this contributes to the global crisis of antibiotic resistance.
The dosage of Cefuroxime for adults varies significantly depending on the type and severity of the infection being treated. For oral Cefuroxime Axetil, the standard dose for most respiratory or skin infections is 250 mg to 500 mg taken twice daily (every 12 hours) for 7 to 10 days. For acute bacterial sinusitis, a dose of 250 mg twice daily is common. In the case of early Lyme disease, the recommended dose is 500 mg twice daily for 20 days. For uncomplicated urinary tract infections, a lower dose of 125 mg to 250 mg twice daily may be sufficient.
When using Cefuroxime Sodium (parenteral), the typical adult dose is 750 mg to 1.5 grams every 8 hours. For life-threatening infections or infections caused by less susceptible organisms, the dose may be increased to 1.5 grams every 6 hours. For surgical prophylaxis, a 1.5-gram dose is usually administered intravenously about 30 to 60 minutes before the first surgical incision, with additional 750 mg doses given every 8 hours for prolonged procedures.
Pediatric dosing is primarily based on the child's weight and the specific infection. For Cefuroxime Axetil oral suspension in children aged 3 months to 12 years, the standard dose is 20 mg/kg/day to 30 mg/kg/day, divided into two doses (every 12 hours), with a maximum daily dose of 1,000 mg. For acute otitis media (middle ear infection), a higher dose of 30 mg/kg/day is often utilized to ensure efficacy against resistant strains.
For Cefuroxime Sodium (IV/IM) in pediatric patients older than 3 months, the dosage ranges from 50 to 100 mg/kg/day divided into three or four equal doses. In cases of bacterial meningitis, higher doses of up to 200 to 240 mg/kg/day IV may be required. Your pediatrician will calculate the exact dose based on the child's weight and the severity of the illness.
Since Cefuroxime is primarily excreted by the kidneys, patients with impaired renal function require dose adjustments to prevent drug accumulation and toxicity. If the creatinine clearance (CrCl) falls below 20 mL/min, the dosing frequency is typically reduced. For example, a patient with a CrCl of 10-20 mL/min might receive the standard dose every 12 hours instead of every 8 hours. For those with CrCl less than 10 mL/min, the dose may be given once every 24 hours.
No specific dosage adjustments are generally required for patients with liver disease, as Cefuroxime is not significantly metabolized by the liver. However, these patients should still be monitored closely for any signs of adverse reactions.
Elderly patients are more likely to have decreased renal function. Therefore, dose selection should be cautious, often starting at the lower end of the dosing range, and renal function should be monitored throughout the course of treatment.
For the best results and to minimize side effects, follow these guidelines:
If you miss a dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and return to your regular schedule. Do not double the dose to catch up, as this increases the risk of side effects.
An overdose of Cefuroxime can cause neurological irritation and may trigger seizures, particularly in patients with kidney disease. Symptoms of overdose may include nausea, vomiting, and diarrhea. If an overdose is suspected, contact a poison control center or seek emergency medical attention immediately.
> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or stop the medication without medical guidance.
Cefuroxime is generally well-tolerated, but like all antibiotics, it can cause side effects. The most frequently reported adverse reactions involve the gastrointestinal system. These include:
While rare, some side effects are medical emergencies. Stop taking Cefuroxime and call your doctor immediately if you experience:
> Warning: Stop taking Cefuroxime and call your doctor immediately if you experience any of these serious symptoms.
Cefuroxime is typically intended for short-term use (7 to 20 days). Prolonged or repeated use can lead to:
There are currently no FDA black box warnings for Cefuroxime. However, this does not mean the drug is without risk. The most significant warnings provided by the FDA concern the risk of severe hypersensitivity reactions and the potential for C. difficile-associated diarrhea.
Report any unusual symptoms or persistent side effects to your healthcare provider. Monitoring your body's response to the medication is a critical part of safe antibiotic therapy.
Before starting Cefuroxime, it is essential to provide your healthcare provider with a complete medical history. Cefuroxime is a potent medication that requires careful oversight. Patients should be aware that this drug is only for bacterial infections; using it for viral infections increases the risk of developing drug-resistant bacteria, which is a significant public health concern. If you have a history of asthma or significant allergies, you may be at a higher risk for a reaction.
As of the current 2024-2026 clinical guidelines, there are no FDA black box warnings for Cefuroxime. It is considered a relatively safe antibiotic when used as directed by a qualified medical professional.
One of the most critical precautions involves hypersensitivity. If you have ever had a severe allergic reaction to penicillin, you must inform your doctor. There is a risk of cross-sensitivity (approximately 3% to 10%) between penicillins and cephalosporins. This means that if you are allergic to one, you might be allergic to the other. A severe reaction can lead to anaphylaxis, which is a life-threatening emergency.
Almost all systemic antibiotics, including Cefuroxime, can cause C. diff-associated diarrhea. This condition ranges in severity from mild diarrhea to fatal colitis (inflammation of the colon). Antibiotics change the normal flora of the colon, allowing C. diff to grow. If you develop diarrhea that is watery or bloody, do not use anti-diarrheal products like loperamide (Imodium), as they can make the condition worse by keeping the toxins in your system. Contact your doctor immediately.
Because Cefuroxime is cleared by the kidneys, patients with kidney disease must be monitored closely. High blood levels of the drug can lead to neurological complications, including seizures. Your doctor will likely perform blood tests to check your kidney function before and during treatment if you have a history of renal issues.
Cephalosporins can sometimes interfere with blood clotting by affecting Vitamin K levels. Patients at risk include those with renal or hepatic impairment, poor nutritional status, or those on long-term antibiotic therapy. In these cases, your doctor may monitor your prothrombin time (a test that measures how long it takes for your blood to clot).
If you are on a prolonged course of Cefuroxime (especially the IV form), your healthcare provider may require periodic lab tests:
Cefuroxime is not generally known to cause significant impairment. However, some patients report dizziness or headaches. You should observe how the medication affects you before driving or operating heavy machinery.
While there is no specific "disulfiram-like" reaction (nausea, vomiting, flushing) associated with Cefuroxime and alcohol (unlike some other antibiotics like metronidazole), it is generally advised to avoid alcohol while fighting an infection. Alcohol can dehydrate the body and interfere with the immune system's ability to recover.
There is no withdrawal syndrome associated with Cefuroxime, and tapering is not required. However, the most important rule of discontinuation is not to stop early. Even if symptoms disappear, the bacteria may still be present. Stopping early can lead to a relapse that is harder to treat.
> Important: Discuss all your medical conditions, especially kidney disease and allergies, with your healthcare provider before starting Cefuroxime.
While Cefuroxime does not have many absolute contraindications with other drugs, it should not be used in patients who have a known severe hypersensitivity to other cephalosporin antibiotics. Using it in these patients can lead to fatal anaphylactic shock.
Cefuroxime can cause false results in certain medical tests:
For each major interaction, the primary management strategy is monitoring. Whether it is monitoring kidney function, blood clotting times, or using backup birth control, being aware of these interactions allows for safer and more effective treatment.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, including over-the-counter drugs.
Cefuroxime must NEVER be used in the following circumstances:
In these situations, the healthcare provider will perform a careful risk-benefit analysis:
Cross-sensitivity refers to the phenomenon where the immune system identifies different drugs as being the same because of their chemical structure. Cefuroxime contains a beta-lactam ring, similar to penicillins, carbapenems (like Meropenem), and monobactams. While the risk of cross-reaction with monobactams is very low, the risk with other beta-lactams is significant enough to require a thorough allergy history before the first dose is administered.
> Important: Your healthcare provider will evaluate your complete medical history, including all past drug reactions, before prescribing Cefuroxime. Always carry a list of your allergies with you.
Cefuroxime is classified by the FDA as Pregnancy Category B. This means that animal reproduction studies have failed to demonstrate a risk to the fetus, but there are no adequate and well-controlled studies in pregnant women.
Cefuroxime is excreted in human milk in small amounts. The American Academy of Pediatrics considers Cefuroxime to be generally compatible with breastfeeding. However, potential effects on the nursing infant include:
Cefuroxime is approved for use in pediatric patients as young as 3 months of age. It is widely used for ear infections, throat infections, and skin infections in children.
In clinical trials, no overall differences in safety or effectiveness were observed between elderly and younger patients. However, the elderly are more likely to have decreased renal function.
This is the most critical special population for Cefuroxime. For patients with a Creatinine Clearance less than 20 mL/min, the dosing interval must be extended.
Since the liver is not the primary route of elimination, hepatic impairment does not typically require a dose adjustment. However, in patients with severe liver disease (Child-Pugh Class C), the overall health status may necessitate closer monitoring of blood counts and clotting factors.
> Important: Special populations require individualized medical assessment. Always inform your doctor if you are pregnant, nursing, or have a history of kidney issues.
Cefuroxime is a bactericidal beta-lactam antibiotic. Its primary mechanism of action is the inhibition of bacterial cell wall synthesis. It achieves this by binding to specific Penicillin-Binding Proteins (PBPs)—specifically PBP 1A, 1B, 2, and 3—which are enzymes located on the inner membrane of the bacterial cell wall. These enzymes are responsible for the transpeptidation (cross-linking) of peptidoglycan chains. Peptidoglycan is the structural component that provides the cell wall with its rigidity. By blocking this cross-linking, Cefuroxime weakens the cell wall, leading to osmotic instability and cell death. It is particularly resistant to many beta-lactamase enzymes produced by Gram-negative bacteria, which allows it to remain effective where earlier antibiotics might fail.
As a cephalosporin, Cefuroxime exhibits time-dependent killing. This means that its antimicrobial efficacy is best predicted by the amount of time that the concentration of the drug in the blood remains above the Minimum Inhibitory Concentration (MIC) of the infecting bacteria. Unlike some antibiotics that work better with one large dose (concentration-dependent), Cefuroxime works best when a consistent level is maintained. This is why it is usually dosed every 8 or 12 hours.
| Parameter | Value |
|---|---|
| Bioavailability | 37% (Fasting) / 52% (With Food) |
| Protein Binding | 33% to 50% |
| Half-life | 1.2 to 1.6 hours |
| Tmax | 2 to 3 hours (Oral) / 15-60 min (IM) |
| Metabolism | Minimal (Axetil is hydrolyzed to Cefuroxime) |
| Excretion | Renal (89% unchanged in urine) |
Cefuroxime is classified as a second-generation cephalosporin. It sits between the first-generation (like Cephalexin), which are great for Gram-positive skin infections, and the third-generation (like Ceftriaxone), which have even broader Gram-negative coverage but sometimes less Gram-positive activity. Cefuroxime is often considered a "workhorse" antibiotic because it balances coverage for both types of bacteria, making it suitable for many common community and hospital infections.
Medications containing this ingredient
Common questions about Cefuroxime
Cefuroxime is a broad-spectrum antibiotic used to treat a wide variety of bacterial infections. It is FDA-approved for treating respiratory tract infections like pneumonia and bronchitis, ear and throat infections, and urinary tract infections. It is also highly effective for skin infections and is a primary treatment for early-stage Lyme disease. Additionally, the injectable form is frequently used in hospitals to prevent infections after surgery. Because it is a second-generation cephalosporin, it can kill many types of bacteria that are resistant to older antibiotics like penicillin or amoxicillin.
The most common side effects of Cefuroxime are gastrointestinal in nature, including diarrhea, nausea, and occasional vomiting. These occur because the antibiotic can affect the natural balance of bacteria in your digestive system. Some patients may also experience a mild headache, dizziness, or a temporary increase in liver enzymes. In women, vaginal yeast infections (thrush) are common due to changes in the body's microbial flora. Most of these side effects are mild and resolve once the treatment is finished, but you should always report persistent symptoms to your doctor.
There is no known dangerous chemical interaction between Cefuroxime and alcohol, unlike some other antibiotics that can cause severe nausea and vomiting when combined with spirits. However, healthcare providers generally recommend avoiding alcohol while you are being treated for an infection. Alcohol can dehydrate your body, disrupt your sleep, and weaken your immune system's ability to fight the illness. Furthermore, both alcohol and Cefuroxime can cause stomach upset, so combining them may increase your discomfort. It is best to wait until you have finished your course and feel fully recovered before consuming alcohol.
Cefuroxime is generally considered safe for use during pregnancy and is classified as FDA Pregnancy Category B. This means that research in animals has not shown any harm to the developing fetus, although human studies are limited. Doctors frequently prescribe Cefuroxime to pregnant women for conditions like urinary tract infections or sinus infections because the risks of leaving an infection untreated are often greater than the risks of the medication. If you are pregnant or planning to become pregnant, you should discuss the benefits and risks with your healthcare provider to ensure the best care for you and your baby.
Most patients begin to feel an improvement in their symptoms within 48 to 72 hours of starting Cefuroxime. For example, if you are treating a fever or a sore throat, these symptoms usually begin to subside as the bacterial load in your body decreases. However, the exact time depends on the severity and location of the infection. Even if you feel 100% better after just two days, it is vital that you continue taking the medication for the full duration prescribed by your doctor. Stopping too early can allow the remaining bacteria to multiply, leading to a relapse or antibiotic resistance.
You should not stop taking Cefuroxime suddenly unless you are experiencing a severe allergic reaction. While there is no 'withdrawal' effect from stopping an antibiotic, stopping the course before all the bacteria have been killed is dangerous. This can lead to the infection returning, often in a more severe form that is harder to treat. It also contributes to the development of 'superbugs'—bacteria that are resistant to standard antibiotics. If you are bothered by side effects, talk to your doctor about managing them rather than simply stopping the medication on your own.
If you miss a dose of Cefuroxime, you should take it as soon as you remember. If it is almost time for your next scheduled dose (within a few hours), it is better to skip the missed dose and continue with your regular schedule. Never take two doses at the same time to make up for a missed one, as this can increase the likelihood of side effects like nausea or diarrhea. Maintaining a consistent level of the antibiotic in your bloodstream is important for effectively killing the bacteria, so try to use a reminder or an alarm to stay on track with your doses.
Weight gain is not a recognized side effect of Cefuroxime. Antibiotics generally do not affect your metabolism or fat storage in a way that leads to weight changes during a standard 7- to 14-day course. If you notice sudden weight gain or swelling (edema) while taking Cefuroxime, it could be a sign of a different issue, such as a kidney problem or a severe allergic reaction, and you should contact your healthcare provider. Some people may experience temporary bloating due to changes in gut bacteria, but this is not the same as gaining body weight.
Cefuroxime can be taken with many other medications, but there are some important exceptions. You should be cautious if you are taking blood thinners like Warfarin, as Cefuroxime can increase the risk of bleeding. It can also interact with certain stomach acid reducers (like proton pump inhibitors), which may lower the absorption of the oral form. If you are taking birth control pills, the antibiotic might slightly decrease their effectiveness, so using a backup method is often recommended. Always provide your doctor or pharmacist with a full list of your current medications and supplements to avoid potential interactions.
Yes, Cefuroxime is widely available as a generic medication in both its oral (Cefuroxime Axetil) and injectable (Cefuroxime Sodium) forms. Generic versions are required by the FDA to have the same active ingredient, strength, dosage form, and route of administration as the brand-name versions like Ceftin or Zinacef. Generic Cefuroxime is typically much more affordable than the brand-name counterparts and is covered by most insurance plans. Whether you receive the brand-name or the generic, the clinical effectiveness and safety profile remain the same.